Loading…

P450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR‐MDS

Saved in:

Bibliographic Details
Published in:	HemaSphere 2022-06, Vol.6, p.350-351
Main Authors:	Pakulska, U., Angelosanto, N., Mikula, M., Nogai, H., Dudziak, R., Abboud, C., Obacz, M., Goller, K., Cybulska, M., Mazan, M., Kozakowska, M., Rzymski, T.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!